Eastman Chemical Company

Valuation Analysis

About the Company

Eastman Chemical Company en bref

Eastman Chemical Company (EMN) is currently trading at 63,25 € with a market capitalization of 7,2 Md €. The trailing P/E ratio stands at 20.97x, with a forward P/E of 10.35x. The 52-week range spans from 48,91 € to 72,77 €; the current price is 13.1% below the yearly high. Year-over-year revenue growth stands at -4.9%. The net profit margin stands at 4.62%.

💰 Dividende

Eastman Chemical Company pays an annual dividend of 2,93 € per share, representing a yield of 4.63%. The payout ratio stands at 96.53%. The elevated payout ratio reflects a mature dividend policy.

📊 Avis des analystes

15 analystes évaluent Eastman Chemical Company (EMN) au consensus : None. L'objectif de cours moyen est de 73,52 €, soit un potentiel de +16.24% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 64,51 € à 87,18 €.

Eastman Chemical Company : la thèse d'investissement en détail

Eastman Chemical Company (EMN) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Revenue is contracting at -4.9% year-over-year — until that trend reverses, valuation is exposed to further downgrades. With a net margin of just 4.62%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valorisation en contexte

With a PEG ratio of 0.62, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 9.66x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The forward P/E of 10.35x is meaningfully below the trailing 20.97x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Profil de risque

The data points to market-like volatility, elevated short interest (6.45%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Eastman Chemical Company?

Compare top-rated brokers — low fees, trusted providers, fully regulated.